Abstract

Cardiac sarcoidosis (CS) is the scarring of heart muscles by autoimmunity, leading to heart abnormalities and patients with sarcoidosis with cardiac involvements have poor prognoses. Due to the small number of patients, it is difficult to stratify all patients of CS by human leukocyte antigen (HLA) analysis. We focused on the structure of antigen-recognizing pockets in heterodimeric HLA-class II, in addition to DNA sequences, and extracted high-affinity combinations of antigenic epitopes from candidate autoantigen proteins and HLA. Four HLA heterodimer-haplotypes (DQA1*05:03/05:05/05:06/05:08-DQB1*03:01) were identified in 10 of 68 cases. Nine of the 10 patients had low left ventricular ejection fraction (< 50%). Fourteen amino-acid sequences constituting four HLA anchor pockets encoded by the HLA haplotypes were all common, suggesting DQA1*05:0X-DQB1*03:01 exhibit one group of heterodimeric haplotypes. The heterodimeric haplotypes recognized eight epitopes from different proteins. Assuming that autoimmune mechanisms might be activated by molecular mimicry, we searched for bacterial species having peptide sequences homologous to the eight epitopes. Within the peptide epitopes form the SLC25A4 and DSG2, high-homology sequences were found in Cutibacterium acnes and Mycobacterium tuberculosis, respectively. In this study, we detected the risk heterodimeric haplotypes of ventricular dysfunction in CS by searching for high-affinity HLA-class II and antigenic epitopes from candidate cardiac proteins.

Details

Title
Human leukocyte antigen-DQ risk heterodimeric haplotypes of left ventricular dysfunction in cardiac sarcoidosis: an autoimmune view of its role
Author
Yamamoto, Hironori 1 ; Miyashita, Yohei 2 ; Minamiguchi, Hitoshi 1 ; Hosomichi, Kazuyoshi 3 ; Yoshida, Shohei 4 ; Kioka, Hidetaka 1 ; Shinomiya, Haruki 1 ; Nagata, Haruno 5 ; Onoue, Kenji 6 ; Kawasaki, Masato 7 ; Kuramoto, Yuki 1 ; Nomura, Akihiro 8 ; Toma, Yuichiro 5 ; Watanabe, Tetsuya 7 ; Yamada, Takahisa 7 ; Ishihara, Yasuki 9 ; Nagata, Miho 10 ; Kato, Hisakazu 11 ; Hakui, Hideyuki 1 ; Saito, Yoshihiko 12 ; Asano, Yoshihiro 13 ; Sakata, Yasushi 1 

 Osaka University Graduate School of Medicine, Department of Cardiovascular Medicine, Suita, Japan (GRID:grid.136593.b) (ISNI:0000 0004 0373 3971) 
 Osaka University Graduate School of Medicine, Department of Cardiovascular Medicine, Suita, Japan (GRID:grid.136593.b) (ISNI:0000 0004 0373 3971); Osaka University Graduate School of Medicine, Department of Legal Medicine, Suita, Japan (GRID:grid.136593.b) (ISNI:0000 0004 0373 3971) 
 Tokyo University of Pharmacy and Life Sciences, Laboratory of Computational Genomics, School of Life Science, Hachioji, Japan (GRID:grid.410785.f) (ISNI:0000 0001 0659 6325) 
 Kanazawa University Hospital, Department of Cardiovascular Medicine, Kanazawa, Japan (GRID:grid.412002.5) (ISNI:0000 0004 0615 9100) 
 University of the Ryukyus Graduate School of Medicine, Department of Cardiovascular Medicine, Nakagami, Japan (GRID:grid.267625.2) (ISNI:0000 0001 0685 5104) 
 Nara Medical University, Department of Cardiovascular Medicine, Kashihara, Japan (GRID:grid.410814.8) (ISNI:0000 0004 0372 782X) 
 Osaka General Medical Center, Department of Cardiology, Osaka, Japan (GRID:grid.416985.7) (ISNI:0000 0004 0378 3952) 
 Kanazawa University School of Medicine, Innovative Research Center, Kanazawa, Japan (GRID:grid.9707.9) (ISNI:0000 0001 2308 3329) 
 Osaka University Graduate School of Medicine, Department of Cardiovascular Medicine, Suita, Japan (GRID:grid.136593.b) (ISNI:0000 0004 0373 3971); Osaka University Graduate School of Medicine, The 1st Department of Oral and Maxillofacial Surgery, Suita, Japan (GRID:grid.136593.b) (ISNI:0000 0004 0373 3971) 
10  Osaka University Graduate School of Medicine, Department of Cardiovascular Medicine, Suita, Japan (GRID:grid.136593.b) (ISNI:0000 0004 0373 3971); Kyoto University Graduate School of Medicine, Department of Medical Ethics and Medical Genetics, Kyoto, Japan (GRID:grid.258799.8) (ISNI:0000 0004 0372 2033) 
11  Osaka University Graduate School of Medicine, Department of Medical Biochemistry, Suita, Japan (GRID:grid.136593.b) (ISNI:0000 0004 0373 3971) 
12  Nara Prefecture Seiwa Medical Center, Department of Cardiovascular Medicine, Nara, Japan (GRID:grid.136593.b) 
13  Osaka University Graduate School of Medicine, Department of Cardiovascular Medicine, Suita, Japan (GRID:grid.136593.b) (ISNI:0000 0004 0373 3971); National Cerebral and Cardiovascular Center, Department of Genomic Medicine, Suita, Japan (GRID:grid.410796.d) (ISNI:0000 0004 0378 8307) 
Pages
19767
Publication year
2023
Publication date
2023
Publisher
Nature Publishing Group
e-ISSN
20452322
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2889491823
Copyright
© The Author(s) 2023. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.